BOR15001L7

BOR15001L7 is a natural product under development as a topical treatment for cold sores (herpes labialis), specifically in patients with recurrent herpes labialis. It is being evaluated in clinical trials to determine its safety and efficacy compared to docosanol 10% cream, with the primary goal of demonstrating non-inferiority based on healing time. The drug is developed by Laboratoire Boreaderme and has been tested in open-label Phase 2 studies. Its mechanism of action has not been explicitly described in available sources, but it is positioned as an alternative topical therapy for managing symptoms such as pain, tingling, itching, and burning associated with herpes labialis.